Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Anticancer Research|March 12, 1998
Late pulmonary toxicity after treatment for Hodgkin's diseaseF Villani, P De Maria, V Bonfante, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVDV Bonfante, A Santoro, S Viviani, et al.Cell Biology and Toxicology|August 30, 2003
A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug developmentA Casartelli, M Bonato, P Cristofori, et al.British Journal of Cancer|April 7, 1998
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implicationsS Viviani, E Camerini, V Bonfante, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's diseaseL Devizzi, L Maffioli, V Bonfante, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experienceG Bonadonna, A Santoro, A M Gianni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapyA Santoro, G Bonadonna, P Valagussa, et al.International Journal of Radiation Oncology, Biology, Physics|November 15, 1994
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage)M Zanini, S Viviani, A Santoro, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPPV Bonfante, A Santoro, S Viviani, et al.British Journal of Haematology|November 25, 1998
Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's diseaseV Bonfante, S Viviani, A Santoro, et al.Pageof 5